Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near $180

28th November 2017 Uncategorised 0

Over the years, as Pfizer’s Prevnar 13 has grown into the company’s biggest product and the world’s best-selling vaccine, its price tag has shot up considerably as well. Now, the superstar vaccine is set for another price hike in 2018, according to Kaiser Health News.

More: Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near 0
Source: fierce